Detalhe da pesquisa
1.
An HLA-DR11/DQ3 haplotype with a DRB1*0301 sequence motif in the third hypervariable region of the HLA-DR beta-1 chain: molecular and serological analysis of its generation in a European Caucasian family.
Tissue Antigens
; 74(4): 330-5, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19624613
2.
Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, -DQA1*0201, -DQB1*0303 extended haplotype.
J Invest Dermatol
; 100(6): 749-52, 1993 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-8496614
3.
Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study.
J Invest Dermatol
; 106(4): 711-4, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-8618009
4.
How many probes are needed for HLA-DPB1 typing with sequence-specific oligonucleotide probes? A theoretical approach using computer simulation.
Hum Immunol
; 30(1): 22-6, 1991 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-2001974
5.
Semiautomated HLA-DQB1 typing by fluorescent dye photometry of amplified DNA on microtiter plates.
Hum Immunol
; 39(1): 1-8, 1994 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-7910159
6.
TAP2 gene polymorphism segregates with DR-DQ in DR/DP recombinant siblings.
Hum Immunol
; 38(3): 217-20, 1993 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-8106280
7.
Analysis of TAP2 and HLA-DP gene polymorphism in psoriasis.
Hum Immunol
; 40(4): 299-302, 1994 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8002377
8.
Alloreactive T-cell clones raised in an HLA-B/D crossing-over family dissect HLA-DR5 and HLA-DQw3 subtypes.
Hum Immunol
; 29(2): 117-30, 1990 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-1701168
9.
Interleukin 2 production by alloantigen-stimulated CD4+ and CD8+ human T cell subsets: frequency of HLA class I or class II-reactive precursor cells and clonal specificity of activated T cells.
Immunobiology
; 179(4-5): 366-81, 1989 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-2575597
10.
Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients.
Bone Marrow Transplant
; 23(8): 779-81, 1999 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-10231139
11.
The incidence of DPB1 differences between serological and mixed lymphocyte culture matched unrelated individuals: implications for selection of bone marrow donors.
Bone Marrow Transplant
; 9(3): 157-60, 1992 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-1387332
12.
HLA and bone marrow transplantation.
Arch Immunol Ther Exp (Warsz)
; 43(2): 83-7, 1995.
Artigo
em Inglês
| MEDLINE | ID: mdl-8744720
13.
Effect of cytokines on proliferation of Epstein Barr virus-transformed B lymphocytes.
Hybridoma
; 9(1): 1-8, 1990 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-2155870
14.
Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.
Hybridoma
; 8(4): 467-74, 1989 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-2476377
15.
Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype.
Bone Marrow Transplant
; 42(3): 219-20, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18560413
16.
Immunoglobulin gene usage in diabetes-associated human monoclonal antibodies recognizing glutamate decarboxylase.
Ann N Y Acad Sci
; 764: 457-60, 1995 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-7486565
17.
Evidence for a lymphocyte activation determinant coded by the HLA region different from HLA-DR, DQ, and DP.
Transplant Proc
; 19(1 Pt 1): 866-9, 1987 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-3824496
18.
An autoreactive T cell clone derived after allostimulation in vitro: evidence for recognition of a polymorphic self major histocompatibility complex class II gene product.
Transplant Proc
; 19(1 Pt 1): 875-7, 1987 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-3493567
19.
Molecular matching in renal transplantation.
Transplant Proc
; 24(6): 2475-7, 1992 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1465838
20.
[Indications for irradiated blood components: dose and side effects]. / Indikation für bestrahlte Blutkomponenten: Dosis und Nebenwirkungen.
Beitr Infusionsther
; 31: 70-3, 1993.
Artigo
em Alemão
| MEDLINE | ID: mdl-7693267